Director/PDMR Shareholding
15 November 2021 16:00 GMT Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that on 12 November 2021 an award of AstraZeneca American Depositary Shares (ADSs) vested to Dr Aradhana Sarin, Chief Financial Officer. Each ADS represents one half of an Ordinary Share of $0.25 in the Company. In accordance with the Agreement and Plan of Merger, the award was granted under the AstraZeneca Global Restricted Stock Plan at the time of closing of the acquisition of Alexion Pharmaceuticals, Inc. (Alexion) by the Company. It replaced